HDAC inhibitors

Syndax is hit with a setback during the ASCO preview round as lead drug flops in mid-stage study
Endpoints
Fri, 05/18/18 - 12:17 pm
Syndax Pharma
HDAC inhibitors
entinostat
Keytruda
ASCO
Merck, Novartis Blood Cancer Drugs May Shrink Child Tumors, Study Finds
Bloomberg
Wed, 03/30/11 - 12:44 pm
Novartis
Merck
HDAC inhibitors
LBH589
Zolinza